AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.
Alcon enters agreement with Google to in-license its "smart lens" technology for all ocular medical uses.
Lilly and Immunocore enter immunotherapy agreement to co-discover and co-develop new cancer therapies.
AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.
Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.
PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.
According to the National Bioscience Report, the US bioscience industry is on course for continued growth.
NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.
Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.
Handheld Analyzer Improves Accuracy